Insulin Delivery Devices Market

The global Insulin Delivery Devices Market is valued at USD 18.33 Billion in 2021 and is expected to reach USD 33.05 Billion by 2028 with a CAGR of 9.7% over the forecast period.

Insulin Delivery Devices Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2029. The increasing geriatric population is the key factor driving the growth of the Global Insulin Delivery Devices Market.

Market Analysis of Insulin Delivery Devices-

Insulin is a necessary part of the treatment plan for all people with Type 1 diabetes and many with Type 2. Insulin helps get glucose from the bloodstream into the muscle and fat cells to be used for fuel. It cannot be taken as a pill or a swallowed liquid, because it would be broken down by the digestive system before it reached the bloodstream, where insulin does its work. Thus, insulin is injected or infused into the fatty tissue under the skin. Insulin therapy is used for the treatment of people with type 1 diabetes in order to avoid complications arising from hyperglycemia. Insulin is regulated, mainly by subcutaneous insulin injections like vials and syringes, insulin pens, and insulin pumps. In addition to this, various other physiological minimally invasive or noninvasive ways for delivering insulin are oral, buccal, nasal, peritoneal, and transdermal.

The insulin delivery devices market report is segmented on the basis of type, distribution channel, end-user, and region & country level. Based upon type, the global insulin delivery devices market is segmented into an insulin syringe, insulin pens, insulin jet injectors, insulin pumps, insulin needles, and insulin inhalers. On the basis of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Based on end-user, the global insulin delivery devices market is segmented into hospitals, clinics, ambulatory care centers, and home care.     

The regions covered in this Insulin Delivery Devices Market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of Insulin Delivery Devices is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Insulin Delivery Devices Market Players-

Some major key players for Insulin Delivery Devices Market are -

• Animas Corporation
• Becton
• Biocon Ltd.
• Braun Melsungen AG
• CeQur
• Dickinson and Company
• Eli Lilly and Company
• EOFLOW CO. LTD
• Hoffmann-La Roche Ltd.
• Insulet Corporation
• Medtronic plc
• Novo Nordisk A/S
• SOOIL Developments Co. Ltd
• Tandem Diabetes Care Inc.
• Terumo
• Ypsomed Holding AG
• Others

Insulin Delivery Devices Market Key Segmentation-

By Product Type

• Insulin Syringe
• Insulin Pens
• Disposable
• Reusable
• Insulin Jet Injectors
• Insulin Pumps
• Tethered
• Others

By End-User

• Hospital
• Clinics
• Ambulatory Care Centre
• Homecare

By Distribution Channels

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Regional & Country Analysis:

• North America

• U.S.
• Mexico
• Canada

• Europe

• UK
• France
• Germany
• Italy

• The Asia Pacific

• China
• Japan
• India
• Southeast Asia

• South America

• Brazil,
• Argentina
• Columbia

• The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Market Dynamics of Insulin Delivery Devices–

The major factors driving the growth of global insulin device delivery market are the increasing prevalence of diabetes, rising geriatric population, an increase in stoutness, propagation of diabetes management awareness and government propulsion. According to World Health Organization (WHO), the number of people with diabetes are increased from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. Stoutness plays an important role in the growth of the insulin delivery device market. Stoutness is caused due to diet imbalance, junk food leading to various risk factors for diabetes, high blood pressure, heart disease, and others. Increasing awareness about advanced insulin delivery devices among diabetic patients will also augment the demand for insulin delivery devices. The advanced methods for insulin delivery incorporate minimum trespassing in an enhanced manner, lower patients’ burden will positively affect the market growth over the upcoming period.

However, corresponding factors like the high cost of insulin, the rising cost of insurance coverage, needle-phobia of many individuals, uncompromising rules & regulations, high cost of insulin pumps, R&D activity cost, regulatory pressure, and technological issues are some factors that may hamper the growth of the market. Moreover, initiatives taken by various governments and non-government organizations to increase awareness regarding insulin devices and quick advancements in the technology can be opportunities for further growth of the market.

Regional Analysis of Insulin Delivery Devices Market-

The Insulin Delivery Devices Market is segmented into North America, Europe, Asia-Pacific, Latin America, and Africa. North America is expected to capture the largest share of the global insulin delivery devices market owing to the increasing pervasiveness of diabetes and a well-developed healthcare sector. According to Canadian statistics, in the year 2017, 7.3% of Canadian people aged between 12 and older (roughly 2.3 million people) reported being diagnosed with diabetes. Between 2016 and 2017, the percentage of males who reported being diagnosed with diabetes escalates from 7.6% in 2016 to 8.4% in 2017. The percentage of females remained consistent between the two years. On the other hand, the Middle East & Africa is expected to observe slow growth due to less exposure to healthcare services, lack of awareness, and stringent government rules and regulations.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2021:	USD 18.33 Billion
Base year considered	2020
Forecast Period CAGR %:	9.7%
Market Size Expected in 2028:	USD 33.05 Billion
Tables, Charts & Figures:	175
Pages	200
Insulin Delivery Devices Manufacturers	Animas Corporation, Becton, Biocon Ltd., Braun Melsungen AG, CeQur, Dickinson and Company, Eli Lilly and Company, EOFLOW CO. LTD, Hoffmann-La Roche Ltd., Insulet Corporation, Medtronic plc, Novo Nordisk A/S, SOOIL Developments Co. Ltd, Tandem Diabetes Care Inc., Terumo, Ypsomed Holding AG, Others.
Segments Covered	By Type, By End-User, By Distribution Channel
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa